Veniti, armed with $17 million in new financing, moves forward with more testing and an international launch of its Vici venous stent system.
Veniti said it nailed down a $17 million Series C financing it plans to use to advance testing and commercialization of its Vici venous stent system.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1MqxSgO
Cap comentari:
Publica un comentari a l'entrada